SCHEMBL22037580

SCHEMBL22037580

CC1(C)c2cc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)ccc2-c2ccc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.38
▸ KMT2A Q03164 7/20 0.38
▸ MAPT P10636 5/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 4/20 0.38
▸ LMNA P02545 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ATM Q13315 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ RECQL P46063 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743416 1.00 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22038090 0.97 RARA (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19271459 0.96 MEN1 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22309436 0.96 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19885842 0.96 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22545027 0.93 MAPT (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22309437 0.93 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL29339940 0.93 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22039087 0.92 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL24453361 0.92 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 MEN1 3738/4885KMT2A 3571/4885MAPT 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback